SCHEMBL7459653

SCHEMBL7459653

Cc1ccc(S(=O)(=O)NNCCC(=O)O)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.56
KMT2A Q03164 3/20 0.56
RAB9A P51151 1/20 0.56
LMNA P02545 1/20 0.56
POLB P06746 1/20 0.56
MEN1 O00255 1/20 0.51
GAA P10253 2/20 0.50
KDM4E B2RXH2 2/20 0.49
CYP1A2 P05177 2/20 0.49
CYP3A4 P08684 2/20 0.49
CYP2D6 P10635 2/20 0.49
CYP2C9 P11712 2/20 0.49
HPGD P15428 2/20 0.49
ALOX12 P18054 2/20 0.49
CYP2C19 P33261 2/20 0.49
TDP1 Q9NUW8 2/20 0.49
GFER P55789 1/20 0.49
MAPT P10636 1/20 0.49
PKM P14618 1/20 0.49
APOBEC3G Q9HC16 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3864255 0.85 ALDH1A1 (0.57) ALDH1A1KMT2ALMNAMEN1GAA
SCHEMBL4541169 0.83 ALDH1A1 (0.73) ALDH1A1KMT2ALMNAMEN1MAPT
SCHEMBL19346235 0.78 ALDH1A1 (0.69) ALDH1A1KMT2ALMNACYP3A4CYP2C9
SCHEMBL3898275 0.77 LMNA (0.72) ALDH1A1LMNAPKMCA2
SCHEMBL9131405 0.75 POLB (0.79) ALDH1A1KMT2ARAB9ALMNAPOLB
SCHEMBL6279910 0.75 EGFR (0.56) ALDH1A1KMT2ARAB9ALMNAPOLB
SCHEMBL9871290 0.75 ALDH1A1 (0.75) ALDH1A1RAB9ALMNAPKM
SCHEMBL600045 0.75 ALDH1A1 (0.75) ALDH1A1RAB9ALMNAPKM
SCHEMBL11399643 0.74 ALDH1A1 (0.57) ALDH1A1KMT2ARAB9ALMNAPOLB
SCHEMBL7627224 0.74 ALDH1A1 (0.72) ALDH1A1KMT2ARAB9ALMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1040098-A1 INTEGRIN RECEPTOR ANTAGONISTS Merck & Co., Inc. (a New Jersey corp.) (US) 2000-10-04 EP disclosed
WO-1999031061-A1 INTEGRIN RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1999-06-24 WO disclosed